Rev Med UAS
Vol. 11: No. 1. Enero-Marzo 2021
ISSN 2007-8013

Efecto del aceite esencial de Chrysactinia mexicana A. Gray en aislados clínicos de Candida albicans de mujeres con neoplasia intraepitelial cervical

Effect of the essential oil Chrysactinia mexicana A. Gray in isolated clinical studies of Candida albicans in women with cervical intraepithelial neoplasia.

Mendoza-Hernández Cristian1, Medina-de la Cruz Omar1, Díaz-Palma Rosa María1, Carranza-Betancourt Oswaldo1, Gallegos-García Marisol2, Escoto-Chávez Saúl Enrique2, Gallegos-García Verónica1*

  1. Facultad de Enfermería y Nutrición. Universidad Autónoma de San Luis Potosí.
  2. Facultad de Ingeniería. Universidad Autónoma de San Luis Potosí.

*Autor de correspondencia: Gallegos-García Verónica
Dirección: Av. Niño Artillero No. 130. Zona Universitaria. C.P. 78240. veronica.gallegos@uaslp.mx

DOI http://dx.doi.org/10.28960/revmeduas.2007-8013.v11.n1.004

Recibido 22 de Octubre 2020, aceptado 26 de Noviembre 2020


RESUMEN
Introducción. Los aceites esenciales tienen una gran cantidad de compuestos que poseen efecto fungicida y en los últimos años se ha considerado su uso como posibles tratamientos que permitan el control de infecciones. Candida albicans es parte de la microbiota y es una levadura patógena de importancia médica que en ciertas patologías como neoplasia intraepitelial cervical (NIC), diversos cánceres y pacientes con el síndrome de inmunodeficiencia humana puede ocasionar infecciones superficiales o sistémicas. --- Objetivo. Evaluar el efecto fungicida de Chrysactinia mexicana A. Gray sobre aislados clínicos de C. albicans de mujeres potosinas con diferentes grados de NIC. --- Material y métodos. Se extrajo el aceite esencial de Chrysactinia mexicana A. Gray por arrastre de vapor. Se utilizó la técnica de microdilución en placa de 96 pozos para conocer la concentración fungistática y fungicida del aceite esencial y el acetato de linalilo. Se realizaron ensayos de 24h, fase estacionaria y logarítmica de crecimiento sobre 11 aislados clínicos de C. albicans de pacientes con NIC y una cepa ATCC. Posteriormente se observó el crecimiento en cajas de Petri con YPD agar por 48h. --- Resultados. Se observó un efecto fungicida sobre las cepas Ca7 y SC5314 de C. albicans con 3.71mg/ml y 4.64mg/ml respectivamente. La Ca7 de C. albicans mostro inhibición del 100% tubo germinal a la concentración de 0.371mg/ml del aceite esencial de C. mexicana. --- Conclusiones. El aceite esencial de C. mexicana tiene efecto fungicida y fungistático en aislados clínicos de pacientes con NIC.
Palabras Clave: Acetato de linalilo, tubo germinal, fungicida, fungistático

ABSTRACT
Introduction. Essential oils have a large number of compounds that have a fungicidal effect and in recent years their use has been considered as a possible treatment that allows infection control. Candida albicans is a part of the microbiota and is a pathogenic yeast of medical importance that in certain pathologies, such as cervical intraepithelial neoplasia (CIN), various cancers, and patients with human immunodeficiency syndrome, can cause superficial or systemic infections. --- Objective. To evaluate the fungicidal effect of Chrysactinia mexicana A. Gray on clinical isolates of C. albicans from female patients in San Luis Potosi with different degrees of CIN. --- Material and Methods. The essential oil of C. Mexicana was extracted by steam entrainment. The 96-well plate microdilution technique was used to determine the fungistatic and fungicidal concentration of the essential oil and linalyl acetate. 24 h, stationary and logarithmic growth phase tests were performed on 11 clinical isolates of C. albicans from patients with CIN and ATCC strain. Subsequently, growth was observed in petri dishes with YPD agar for 48h. --- Results. A fungicidal effect was observed in C. albicans strains Ca7 and SC5314 with 3.71mg/ml and 4.64mg/ml respectively C. albicans Ca7 showing 100% inhibition of the germ tuve at the concentration of 0.37mg/ml of the essential oil of C. mexicana. --- Conclusions. The essential oil of C. mexicana has a fungicidal and fungistatic effect in clinical isolates from patients with CIN.
Keywords:Linalyl acetate, germ tuve, fungicide, fungistatic


REFERENCIAS

  1. Medina-Villaseñor E, Oliver-Parra P, Neyra-Ortiz E, Pérez-Castro J, Sánchez-Orozco J, Contreras-González N. Neoplasia intraepitelial cervical, análisis de las características clínico patológicas. GAMO. 2014; 13 (1): 12-25.
  2. Li L, Ding L, Gao T, Lyu Y, Wang M, Song L, et al. Association between Vaginal Micro-environment Disorder and Cervical Intraepithelial Neoplasia in a Community Based Population in China. J Cancer. 2020; 11 (2): 284.
  3. Matos A, Da Silva AP, Medeiros R, Bicho M, Bicho MC. Microenvironment in Vagina as a Key-Player on Cervical Cancer: Interaction of Polymorphic Genetic Variants and Vaginal Microbiome as Co-Factors. Cerv. Cancer Screen. Treat. Prev. Univers. Protoc. Ultim. Control 2018.
  4. Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases—estimate precision. J Fungi. 2017; 3 (4): 57.
  5. Cortés JA, Corrales IF. Invasive candidiasis: epidemiology and risk factors. In Fungal Infection, IntechOpen: 2018.
  6. Liang Y, Chen M, Qin L, Wan B, Wang H. A meta-analysis of the relationship between vaginal microecology, human papillomavirus infection and cervical intraepithelial neoplasia. Infect Agent Cancer. 2019; 14 (1): 1-8.
  7. Gallegos-García V, Pan SJ, Juárez-Cepeda J, Ramírez-Zavaleta CY, Martin-del-Campo M. B, Martínez-Jiménez V, et al. A novel downstream regulatory element cooperates with the silencing machinery to repress EPA1 expression in Candida glabrata. Genetics. 2012; 190 (4): 1285-1297.
  8. Reyes-Montes M, Duarte-Escalante E, Martínez-Herrera E, Acosta-Altamirano G, Frías-De LeónMG. Current status of the etiology of candidiasis in Mexico. Rev Iberoam Micol. 2017; 34 (4): 203-210.
  9. Bakkali F, Averbeck S, Averbeck D, Idaomar M. Biological effects of essential oils–a review. Food Chem Toxicol. 2008; 46 (2): 446-475.
  10. García-López JC, Álvarez-Fuentes G, Pinos-Rodríguez JM, Jasso-Pineda Y, Contreras-Treviño HI, Camacho-Escobar MA, et al. Anti-inflammatory Effects of Chrysactinia mexicana Gray Extract in Growing Chicks (Gallus gallusdomesticus) Challenged with LPS and PHA. Int J Curr Microbiol App Sci. 2017; 6 (1): 550-562.
  11. Cárdenas-Ortega NC, Zavala-Sánchez MA, Aguirre-Rivera JR, Pérez-González C, Pérez-Gutiérrez S. Chemical composition and antifungal activity of essential oil of Chrysactinia mexicana Gray. J Agric Food Chem. 2005; 53 (11): 4347-4349.
  12. Cuéllar-Cruz M, Briones-Martin-del-Campo M, Cañas-Villamar I, Montalvo-Arredondo J, Riego-Ruiz L, Castaño I, et al. High resistance to oxidative stress in the fungal pathogen Candida glabrata is mediated by a single catalase, Cta1p, and is controlled by the transcription factors Yap1p, Skn7p, Msn2p, and Msn4p. Eukaryotic Cell. 2008; 7 (5): 814-825.
  13. Devkatte AN, Zore GB, Karuppayil SM. Potential of plant oils as inhibitors of Candida albicans growth. FEMS Yeast Res. 2005; 5 (9): 867-873.
  14. Nikolic M, Smiljkovic M, Markovic T, Cirica A, Glamoclija J, Markovic D, et al. Sensitivity of clinical isolates of Candida to essential oils from Burseraceae family. EXCLI J. 2016; 15: 280.
  15. Takeo K. Resistance of the stationary-phase plasma membrane of Candida albicans to filipin-induced deformation. FEMS Microbiol Lett. 1985; 27 (1): 73-77.
  16. Cuéllar-Cruz M, Castaño I, Arroyo-Helguera O, De Las Peñas A. Oxidative stress response to menadione and cumene hydroperoxide in the opportunistic fungal pathogen Candida glabrata. Mem Inst Oswaldo Cruz. 2009; 104 (4): 649-654.
  17. Blaskó Á, Gazdag Z, Gróf P, Máté G, Sárosi S, Krisch J, et al. Effects of clary sage oil and its main components, linalool and linalyl acetate, on the plasma membrane of Candida albicans: an in vivo EPR study. Apoptosis. 2017; 22 (2): 175-187.
  18. Rodríguez NDLC, Santa-Vélez C. Factores de virulencia para la infección de tejidos queratinizados por Candida albicans y hongos dermatofitos (Virulence factors of Candida albicans and dermatophytes in keratinized tissues infection). CES Medicina. 2012; 26 (1): 43-55.
  19. De Toledo LG, Ramos MADS, Spósito L, Castilho EM, Pavan FR, Lopes ÉDO, et al. Essential Oil of Cymbopogon nardus (L.) Rendle: A Strategy to Combat Fungal Infections Caused by Candida Species. Int J Mol Sci. 2016; 17 (8): 1252.
  20. Gauch LMR, Silveira-Gomes F, Esteves RA, Pedrosa SS, Gurgel ESC, Arruda AC, et al. Effects of Rosmarinus officinalis essential oil on germ tube formation by Candida albicans isolated from denture wearers. Rev Soc Bras Med Trop. 2014; 47 (3): 389-391.
  21. Audirac-Chalifour A, Torres-Poveda K, Bahena-Roman M, Tellez-Sosa J, Martinez-Barnetche J, Cortina-Ceballos B. Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study. PloS One. 2016; 11 (4): e0153274.
  22. García-García RM, Palou-García E. Mecanismos de acción antimicrobiana de timol y carvacrol sobre microorganismos de interés en alimentos. Tem Selec Ing Aliment.. 2008; 2 (2): 41-51.
  23. Braga PC, Dal Sasso M, Culici M, Alfieri M. Eugenol and thymol, alone or in combination, induce morphological alterations in the envelope of Candida albicans. Fitoterapia. 2007; 78 (6): 396-400.
  24. Bona E, Cantamessa S, Pavan M, Novello G, Massa N, Rocchetti A, et al. Sensitivity of Candida albicans to essential oils: are they an alternative to antifungal agents? J Appl Microbiol. 2016; 121 (6): 1530-1545.